ImprimisRx® Announces Supply Agreement with Vision Center Network of America (VCNA)
March 03, 2020 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, March 03, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of...
ImprimisRx’s FDA-Registered Outsourcing Facility Issued California License
December 10, 2019 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...
ImprimisRx to Focus on Investments in Quality at the 2019 American Academy of Ophthalmology Meeting
October 08, 2019 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, Oct. 08, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...
Harrow Health Announces First Quarter 2019 Financial Results
May 09, 2019 16:01 ET
|
Harrow Health, Inc.
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the first quarter 2019. First Quarter 2019 and Other Recent Notable Highlights: ...
ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting
April 30, 2019 07:00 ET
|
Harrow Health, Inc.
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its participation at...